Godfrey Kisigo participated in our Global Reproductive Health Leadership Symposium in February. Godfrey is currently a study coordinator for Center core member Dr. Melissa Watt's Implementation science study on PMTCT care in Tanzania. "Attending the Global Reproductive Health Leadership symposium presented a unique experience to interact with notable researchers from East Africa and Duke University. I enjoyed the mentorship session the most, as it was featured with the presence of my mentor. I believe we have created potential collaborations in reproductive health research across East Africa and Duke University at large. I should not forget to mention that food was amazing, and the organizing committee was rocking." Read more about his experiences here! ...
Faculty Profile: Nimmi Ramanujam Dr. Nimmi Ramanujam serves as the Robert W. Carr, Jr., Professor of Biomedical Engineering, a Professor of Pharmacology and Cancer Biology, and a Research Professor of Global Health at Duke University. Since arriving at Duke twelve years ago, Dr. Ramanujam has founded the Global Women’s Health Technologies Center and the Tissue Optical Spectroscopy Laboratory, through which she researches cervical and breast cancers, women’s health disparities, and the development of diagnostic tools for implementation in low-resource settings. Her team is currently developing a Point of Care Tampon (POCkeT) Colposcope, which will allow women to screen themselves for cervical cancer.
Dr. Ramanujam took a break from her work to discuss cancer research, technology uptake, and the importance of focusing on the horizon of global health innovation.
How did you decide what technologies to work on?
For Dr. Ramanujam, who had already conducted research on cervical and breast cancers, choosing to concentrate on cervical cancer was about prioritizing the “next generation of problems”...
Faculty Profile: Melissa Watt
With research projects in Tanzania and Ghana, and interests ranging from mother-to-child-transmission of HIV to prevention of fetal alcohol syndrome to family planning to sexual trauma, Associate Professor of the Practice Dr. Melissa Watt is a proficient and passionate force in the field of gender-based health research at Duke.
We sat down with Dr. Watt in her office at the Duke Global Health Institute (DGHI) to learn what sparked her interest in global health, what has defined her time as a Duke faculty member, and what excites her about the future.
How did you become involved in global health and choose reproductive health as a focus for your work?
Referencing a process of self-discovery to which her students might relate, Dr. Watt recalled her undergraduate work in African Studies and Public Policy, which aligned with her passion for “international development and how development can best be transformative for women’s equality and women’s rights.”
After completing her undergraduate program at the...
At the end of May, the Irish government will hold a referendum to decide if their long-standing constitutional ban on abortion should be repealed. Currently, unborn fetuses have a right to life equal to living humans, which has been interpreted as a ban on abortion in almost every single circumstance. If the referendum passes, the Irish Parliament will have the power to enact laws regulating abortion. Read the New York Times article for more information on the potential new regulations and Christine Ryan's blog to learn more about abortion law reform. Photo courtesy of: Clodagh Kilcoyne/Reuters ...
People across the U.S. are kicking off 2018 right with health-conscious resolutions. According to Statista, 45% of Americans hope to “lose weight or get in shape” in 2018. But January offers another opportunity to celebrate and jump-start health awareness: it’s Cervical Health Awareness Month. In the U.S. there are between 11,000 and 13,000 new cases of cervical cancer annually, and cervical cancer is the fourth most prevalent form of cancer among women globally. While patients diagnosed with early-stage cervical cancer have 5-year survival rates of up to 91%, the disease becomes far more deadly as cancerous cells spread to other parts of the body. Fortunately, proactive methods like HPV vaccinations and screenings can keep cervical cancer at bay, and mitigate almost all deaths related to cervical cancer. However, access to such healthcare often depends on a woman’s geographic location and socioeconomic status. According to the WHO, “approximately 90% [of] the 270,000 deaths from cervical cancer in 2015 occurred in low- and middle-income countries.” Duke...
In the seminal international human rights treaties there is no express legal guarantee for abortion rights. Nevertheless, since the 1990s, women’s rights activists have used international human rights forums and mechanisms to advance abortion rights. Cumulatively, human rights law can now be said to call for the decriminalization of abortion and the legalization of abortion in cases where the pregnancy threatens the life or health of the woman, is the result of rape or incest, or there is severe fetal impairment. Despite this promising trajectory, international human rights law does not recognize a woman’s right to decide whether to carry a pregnancy to term as a matter of her autonomy, equality or self-determination. One reason for this is advocates have attempted to follow the path of least resistance for abortion rights and focused instead on the right to health, the right to be free from cruel, inhuman and degrading treatment, and the right to privacy. Recognizing unsafe abortion as a major public...
While the use of modern methods of contraception are now commonplace in many countries, one-third of women in developing countries who begin using a modern method of contraception quit within the first year and half quit within two years[i]. Most discontinuation occurs among women who want to avoid pregnancy putting them at risk for unwanted pregnancies, maternal morbidity and mortality[ii]. Traditional measures of contraceptive use are collected retrospectively from population representative surveys conducted only every five years which are not well-suited to measuring contemporary trends in contraceptive discontinuation. This is problematic because advocates and health ministries cannot address concerns in a reasonable amount of time to impact widespread change. "Big Data" can supplement these static sources by providing dynamic, real time tracking of the reasons women discontinue using contraceptives and open up possibilities to prevent discontinuation or help facilitate switching between methods. So what exactly is "Big Data" and how can it supplement traditional reproductive health data? Big data is commonly thought...
"Curious about contraceptive discontinuation? Intrigued by intersections of technology and sexual health? Apply to join the Data+ “Big Data for Reproductive Health” team! This summer, participants will collaborate with Duke Global Health Institute reproductive health investigators, producing a digital resource that repackages basic Demographic and Health Surveys (DHS) information on contraceptive discontinuation as actionable intelligence for family planning organizations. During the 10-week program, students will also seek feedback from RTI researchers and determine appropriate distribution tactics for their social media-integrated platform. Like other Data+ programs, this project is interdisciplinary, combining the fields of computer science, global health, gender, sexuality and feminist studies, public policy and, of course, data. To find out more and apply, click here."...
Faculty Profile: Blandina Mmbaga
Dr. Blandina Mmbaga is the Director of the Kilimanjaro Clinical Research Institute and a pediatrician at the Kilimanjaro Christian Medical Center (KCMC). She has collaborated with Duke University for over 10 years and currently serves as a site leader for the KCMC-Duke collaboration. Her work in reproductive health includes evaluating strategies to prevent mother-to-child-transmission of HIV and working to improve transitions of care and addressing RH needs for perinatally infected adolescents. We sat down with Dr. Blandina Mmbaga to talk about her work in Tanzania and what she believes are some of the biggest reproductive health challenges in her region.
What are the key reproductive health priorities for Tanzania?
Dr. Mmbaga described several systemic health challenges such as infant nutrition, maternal health, and unmet need for family planning. She feels that one of the biggest challenges, despite available treatment mechanisms, is the prevention of mother to child transmission of HIV. “It remains a challenge because there are still new infections”....
This summer, after a long, solo trip across the world, I arrived in East Africa for the first time. As a Master of Science in Global Health student at Duke University, I spent my first year paired with a mentor, Dr. Megan Huchko, working as a research assistant. During that time we worked together to design a research study which I would conduct the following summer in Kenya. Dr. Huchko and I chose to interview HPV positive women from her ongoing cluster-randomized trial to find ways to reduce the substantial loss to follow up seen with a two-visit screen and treat strategy. Upon entering this program, I knew I wanted to work in women’s reproductive health. Cervical cancer is the leading cause of cancer in women in Africa, so having the opportunity to have a hand in research being conducted to reduce that burden is a privilege. Our goal was to improve treatment acquisition among HPV positive women, to reduce...
